ADVERTISEMENT
Videos
Counterpoint: Immunomodulator monotherapy should not be used in practice
08/16/2018
Fernando Velayos, MD, codirector of the Crohn's and Colitis program at the University of California-San Francisco Medical Center, argues the case for why immunomodulators should not be used as monotherapy in treating inflammatory bowel disease.